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Abstract max 300 words 25 
Objectives The aim of the study was to evaluate echocardiographic, morphometric, and biomarker 26 
changes in cats followed between 6 to 24 months of age. 27 
Methods  24 European shorthair cats in a colony were evaluated at birth for body weight (BW) 28 
and at 6, 12, 18 and 24 months of age for morphologic variables (BW, body condition score [BCS], 29 
head length [HL]  and width [H]), N-terminal B-type natriuretic peptide (NT-proBNP), insulin-like 30 
growth factor-1 (IGF-1), and echocardiographic measurements. 31 
Results BCS, HW, NT-proBNP, left ventricular free wall in diastole and left atrium diameter 32 
increased significantly until 12 months, while HL and interventricular septum in diastole (IVSd) 33 
increased significantly until 18 months, and BW and aortic diameter (Ao) increased significantly 34 
until 24 months. IGF-1 increased significantly until 12 months though decreased significantly 35 
thereafter until 18 months. There were significant associations (R2 ≥ 0.6) between IVSd and HL, 36 
between Ao and BW, and between IVSd and change in IGF-1 in the 6 months before the respective 37 
time point.  38 
Conclusions and relevance Associations between body and cardiac measures have been described 39 
in adult cats and cats with cardiac hypertrophy. This study suggests comparable associations in 40 
healthy cats evaluated in early adult life; however, future studies including larger numbers of cats 41 
and more time points earlier and later in life are needed to determine any potential relationship 42 
between early growth in cats and echocardiographic measurements later in life. 43 
 44 
 45 
 46 
 47 
 48 
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Introduction 49 
There is a possible interaction between body size and cardiac health in cats. Cats with hypertrophic 50 
cardiomyopathy (HCM) are skeletally larger (i.e., larger heads, vertebrae, and longer humeri) and 51 
heavier at diagnosis.1-4 They are also heavier at an early age compared to cats without HCM.5 A 52 
potential mechanism for this interaction involves insulin resistance and/or growth hormone – 53 
insulin-like growth factor (IGF)-1 axis, as binding of insulin and IGF-1 to their receptors on the 54 
cardiomyocyte stimulates myocardial protein synthesis and can cause ventricular hypertrophy.6-8  55 
Some, but not all studies have identified insulin resistance and elevated growth hormone or IGF-1 56 
concentrations in cats with HCM,2, 4, 5, 9 and cats with asymptomatic HCM can have higher body 57 
condition score (BCS), serum insulin, and circulating cardiac biomarkers.10 58 
Multiple studies have identified associations between bodyweight (BW) and left ventricular 59 
measurements in healthy cats and cats with HCM.11-18 These studies show differences in study 60 
design, with primarily intact cats that were all or mostly adults, including single or different breeds, 61 
and different gender ratios. All these studies examined the cats at one single time point, and did 62 
not report BCS, making it impossible to evaluate how many of the cats in these previous studies 63 
were ideal body weight or overweight/obese, which would identify possible confounded 64 
associations between BW and echocardiographic measurements. A previous study in cats with 65 
asymptomatic HCM showed significant associations between circulating cardiac biomarkers, 66 
echocardiography, BW, and BCS.10  67 
Programming is the process of long-term effects from a positive or negative event during a 68 
sensitive or critical period of development. More specific, programming can result from early life 69 
experiences and impact the development of subsequent cardiac disease. Fetal programming has 70 
been shown in several animal and human studies, showing amongst others the effect of alterations 71 
in maternal nutrition on fetal growth and heart disease.19 In cats, a possible relationship between 72 
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growth and cardiac measures can be extrapolated from the associations between BW and left 73 
ventricular measurements at adult age, and the possible interaction between body size and cardiac 74 
health. Although previous studies have provided information on growth in cats with HCM5 or 75 
LVH,2 growth was evaluated retrospectively. One study of Maine Coon cats retrospectively 76 
collected information on body weight at 6 and 12 months of age and showed that cats with HCM 77 
were larger at 6 and 12 months than cats without HCM.5 Another study looked at the effect of 78 
growth on cardiac health at adult age.2 Cats between 3-7 years of age in a colony were 79 
retrospectively reviewed for body weight at 6, 12, and 18 months of age, and underwent 80 
echocardiography, blood analysis and morphologic evaluation.  In that study, 50% of cats had 81 
echocardiographic evidence of left ventricular hypertrophy (LVH), which was significantly 82 
associated with head width (HW), BW, N-terminal B-type natriuretic peptide (NT-proBNP), and 83 
IGF-1 concentrations.  However, echocardiography was only performed at a single time point with 84 
cats at different ages.  Other limitations of the study were that BW was not available for all cats 85 
until 6 months of age, BCS were not available during growth, and cats ate a variety of diets during 86 
growth and throughout adulthood.  A prospective study evaluating BW, skeletal size, BCS, and 87 
echocardiographic measurements would be a next step in better understanding the relationship 88 
between cardiac measures and body size from young age through adulthood. Therefore, the 89 
objective of this study was to prospectively evaluate changes in echocardiographic measures, 90 
morphologic variables, and circulating blood marker during the first two years of life in cats. 91 
 92 
 93 
 94 
 95 
 96 
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Materials and Methods 97 
Twenty-four female European shorthair cats from 11 different litters (1-5 cats per litter) were 98 
included in the study. These cats were participating in a separate observational nutritional study 99 
from birth until 24 months of age, where the maximum sample size was defined as 24 cats. 100 
Furthermore, the sample size of 24 cats was suitable for both the capacity of the research facility 101 
to guarantee animal welfare and to ensure that the sampling workload could be conducted in 102 
reliable conditions by one person in order to avoid manipulation bias.  Cats were habituated to 103 
human contact and manipulation between birth and 6 months of age, and all cats were group-housed 104 
in a colony in compliance with EU regulations and were fed ad libitum.  Cats were fed a 105 
growth/reproduction diet (Royal Canin Mother and Babycat, Royal Canin SAS) from birth until 106 
weaning, a growth diet (Royal Canin Kitten, Royal Canin SAS) from weaning until 10.5 months 107 
of age, and a commercial adult diet (Royal Canin Neutered Young Male, Royal Canin SAS) from 108 
10.5-24 months of age. All cats were neutered at 8 months of age.  Data from morphometric 109 
measurements, echocardiography, and blood sampling were obtained at time points 6 months, 12 110 
months, 18 months, and 24 months. Body weight at birth was also recorded.  Measurements were 111 
performed in conscious cats with no sedation.  Morphometric measures included BW, BCS (9-112 
point scale) and head length (HL), and HW.  HL and HW were measured according to previously 113 
described techniques.4  Head measurements and BCS were performed by the same person at each 114 
time point.  All cats underwent physical examination and echocardiography (two-dimensional [2-115 
D], M-mode, and color flow Doppler echocardiography (GE Vivid 7 Dimension, General Electric 116 
Systems), performed by a single board-certified veterinary cardiologist [DJC]) using a 7.5 mHz 117 
probe on Harmonic mode-octave at the highest frame rate available. Cats were scanned from 118 
beneath while in right lateral recumbence to obtain 2-D and M-mode images from right parasternal 119 
views. Loops were recorded of the right parasternal long-axis four-chamber view, the right 120 
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parasternal long-axis left ventricular (LV) outflow (‘5-chamber’) view, the right parasternal short-121 
axis view at the level of the papillary muscles, and the right parasternal short-axis view at the level 122 
of the aortic valve. M-mode images were guided from 2-D images of the right parasternal short-123 
axis view at the level of the papillary muscles.20 124 
Measurements were made from recorded images. All LV wall thickness measurements 125 
were made from either 2-D or M-mode images. 2-D maximal LV wall thickness was measured on 126 
the first frame after mitral valve closure on the long axis four- and five-chamber view or at the 127 
frame with the largest end-diastolic left ventricular internal diameter in diastole (LVIDd) in the 128 
short axis view at the level of the papillary muscles. A leading-edge-to-leading-edge method of 129 
measurement was used, being careful to exclude the pericardium, false tendons, or papillary 130 
muscles. M-mode measurements were taken in a right parasternal short-axis view at the level of 131 
the papillary muscles using the leading-edge to leading-edge method.20 At least three 132 
measurements were made of the thickest region identified for each view of the end-diastolic 133 
interventricular septum (IVSd) and left ventricular free wall (LVWd), recording the largest 134 
repeatable value. All cats were assessed for focal wall hypertrophy from the right parasternal long-135 
axis inflow and outflow views. 136 
The size of the left atrium (LA) was assessed using two separate methods: using 2-D images 137 
from a right parasternal short-axis view to calculate the ratio of diastolic LA diameter to aortic root 138 
(Ao) diameter (LA:Ao) measured on the first frame after aortic valve closing and using a right 139 
parasternal long-axis four-chamber view to measure the diameter of the LA measured parallel with 140 
the mitral annulus in the last frame before mitral valve opening.3 At least three measurements were 141 
made of each variable, recording an average value for each. The presence or absence of systolic 142 
anterior motion of the mitral valve was assessed on a 2-D right parasternal long-axis LV outflow 143 
view, using cine loop played back at reduced speed and by visualization of characteristic colour 144 
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Doppler flow.20-22Simultaneous electrocardiographic monitoring was not possible due to cat 145 
compliance.23 Unsedated blood pressure was measured by a single veterinarian in a quiet 146 
environment using Doppler technique, using the mean value of three separate measurements.   147 
 Blood was collected after food restriction for approximately 10 hours at each time point for 148 
NT-proBNP and IGF-1.  EDTA plasma was collected at specified time points and stored at -20C 149 
for batch analysis. Analyses for IGF-1 (IGF-1 RIA CT, Mediagnost) and NT-proBNP (Feline 150 
CardioPet NT-proBNP, IDEXX Laboratories) were performed by commercial laboratories.   151 
 152 
Statistical methods 153 
Linear Mixed models were used for modelling the effect of Time (6, 12, 18 and 24 months) on the 154 
echocardiographic measurements (2-D-LVIDd, 2-D-IVSd, 2-D-LVWd, Ao, LA, LA:Ao, M-IVSd, 155 
M-LVIDd and M-LVWd), morphologic variables (BW, BCS, HL and HW) and blood markers 156 
(IGF-1 and NT-proBNP). NT-proBNP data were log transformed for respecting model 157 
assumptions (normally distributed residuals and homoscedasticity). Tukey HSD was applied for 158 
multiple comparisons between time points and the level of significance was set at 0.05% for two-159 
sided tests. In order to evaluate the association between echocardiographic measurements and 160 
morphologic and biomarker variables, a linear mixed model was developed for each of the 161 
echocardiographic measurements as dependent variable and morphologic variables and blood 162 
markers as independent variables. Time and its interaction with other independent variables were 163 
also modelled as fixed effects. Cat factor was modelled as random term. Both directions stepwise 164 
linear mixed model regression was then applied in order to select most relevant morphologic and 165 
biomarkers variables and avoid multicollinearity. 166 
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Associations between echocardiographic variables and the evolution of independent variables 167 
during the previous 6 months were then evaluated. Independent variables were transformed into 168 
the difference over a 6-month period (6 to 12 months, 12 to 18 months and 18 to 24 months) and 169 
combined respectively with dependent variables at 12, 18 and 24 months. Linear mixed models 170 
were then developed for each of the echocardiographic measurements as dependent variable and 171 
Time (12, 18 and 24 months) and evolutions on 6 months periods of morphologic and biomarkers 172 
variables (6 to 12 months, 12 to 18 months and 18 to 24 months) as independent variables. Time 173 
and its interaction with other independent variables were also modelled as fixed effects. Cat factor 174 
was modelled as random term. Both directions stepwise linear mixed model regression was then 175 
applied in order to select most relevant morphologic and biomarkers variables and avoid 176 
multicollinearity.  177 
Results were obtained in RStudio Version 1.1(www.rstudio.com, RStudio Inc). Linear mixed 178 
models were calculated from the lme4 function of LmerTest package 24 and the function step from 179 
the same package was used for the stepwise regression. Tukey HSD was applied from emmeans 180 
function from emmeans package (https://CRAN.R-project.org/package=emmeans, R package 181 
version 1.4.1.). Results are expressed as median and range (minimum, maximum). 182 
 183 
 184 
 185 
 186 
 187 
 188 
 189 
 190 
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Results 191 
Median birthweight was 0.125 kilograms, ranging from 0.100 to 0.170 kilograms. All 24 192 
cats completed the follow up between 6 and 24 months of age. Changes over time in BW, BCS, 193 
HL, HW, IGF-1, and NT-proBNP are described in Table 1. BW continuously increased 194 
significantly between 6 and 24 months. Body condition score and HW increased significantly until 195 
12 months; however, HL increased significantly until 18 months. The prevalence of cats that were 196 
overweight or obese (i.e., >5/9 BCS) was 38% at 6 months, 79% at 12 months, 88% at 18 months, 197 
and 88% at 24 months.   198 
None of the cats had evidence of structural heart disease on echocardiography at any time 199 
point, and there was no identification of focal wall hypertrophy. Changes in echocardiographic 200 
measurements over time are shown in Table 2. 2-D-LVWd, LA-max, M-mode LVIDd, and M-201 
mode LVWd increased significantly until 12 months;  however, 2-D-IVSd increased significantly 202 
until 18 months and Ao diameter increased significantly until 24 months. Median (range) of heart 203 
rate at the different time points was 178 (148-240) at 6 months, 152 (120-176) at 12 months, 152 204 
(112-180) at 18 months, and 160 (128-200) at 24 months of age. Median (range) of blood pressure 205 
(mmHg) at the different time points was 122 (102-143) at 6 months, 148 (118-163) at 12 months, 206 
156 (130-180) at 18 months, and 153 (112-207) at 24 months of age. Blood pressure was ≥180 207 
mmHg in 1 cat at 18 months of age and 2 cats at 24 months of age. No cat had a cardiac murmur 208 
at the age of 6 and 12 months, 1 cat had a murmur (I/VI) at 18 months but not at 24 months, and 2 209 
cats had a murmur (I/VI) at 24 months of age. No cat had a gallop rhythm at 6 months, 1 cat had a 210 
gallop rhythm at 12 months but not at 18 months, and 1 cat had a gallop rhythm at 24 months of 211 
age. 212 
NT-proBNP decreased significantly between 6 and 12 months but did not change 213 
significantly thereafter. Two of the 24 cats had an NT-proBNP concentrations >100 pmol/L (<100 214 
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pmol/L is considered unlikely to have heart disease).25 One of these was at 6 months of age (117 215 
pmol/L) and the other was from a separate cat at 24 months (122 pmol/L).  The cat with the elevated 216 
value at 24 months had an intermittent grade I/VI cardiac murmur auscultated at that time but no 217 
other cardiac abnormalities were noted for either cat.  Other causes for elevated NT-proBNP could 218 
not be identified in either cat.  219 
Nineteen of the 24 cats had IGF-1 concentrations >350 ng/mL (the upper reference value for 220 
healthy cats established by the lab analyzing the samples) at 6, 12, 18, or 24 months of age, with 5 221 
cats having IGF-1 concentrations > 665 ng/mL and 1 cat with IGF-1 concentration between 800 222 
and 1000 ng/mL,26 all at 12 months of age. IGF-1 increased significantly between 6 and 12 months 223 
and then decreased significantly between 12 and 18 months. 224 
Table 3 shows the associations between dependent variables (2-D-LVIDd, 2-D-IVSd, 2-D-225 
LVWd, Ao, LA, LA:Ao, M-IVSd, M-LVIDd and M-LVWd) and the independent variables time, 226 
morphologic variables (BW, BCS, HL and HW) and blood markers (IGF-1 and log transformed 227 
NT-proBNP) which were selected by stepwise regression. Interaction between time and 228 
morphologic  variables or blood markers are not presented because none of them were selected 229 
from stepwise regression. There is a significant impact of time on 2-D-LVIDd, 2-D-IVSd, 2-D-230 
LVWd. Those echocardiographic measurements are also significantly associated with HW, HL and 231 
both BW and HW respectively. Aortic diameter and LA were significantly associated with BW 232 
with no impact of time. LA:Ao, M- LVIDd and M-IVSd were only significantly associated with 233 
time.  Only dependent variable M-LVWd was significantly associated to both a morphologic 234 
variable (HL) and blood marker variable (NT-proBNP). Moreover, there was no impact of time on 235 
this measurement. Overall, echocardiographic measurements were more frequent associated with 236 
morphologic variables (BW, HL, and HW but not BCS) than with blood markers. Associations 237 
were strongest between 2-D-IVSd and HL (R2 = 0.58), and between Ao and BW (R2 = 0.58). 238 
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Table 4 shows the statistically significant associations between dependent variables and 239 
evolution of morphologic and biomarkers in the previous 6 months (Table 4). There was a 240 
significant impact of time on 2-D-LVIDd and M-IVSD, Ao and 2D-IVSD. 2-D-LVIDd and M-241 
IVSD were associated with none of morphologic and biomarkers variable evolution. There was an 242 
association between Ao and BW and 2D-IVSD was associated with both a morphologic marker 243 
(HL) and a biomarker (IGF-1). 2-D-LVWd was as well associated with both a morphologic marker 244 
(HL) and biomarkers (NT-proBNP and IGF-1), and LA:Ao with IGF-1 but with no impact of time. 245 
In contrast to the associations at separate time points, echocardiographic measurements were more 246 
frequent associated with changes in blood markers than changes in morphologic variables during 247 
time periods.  248 
 249 
 250 
 251 
 252 
 253 
 254 
 255 
 256 
 257 
 258 
 259 
 260 
 261 
 262 
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Discussion 263 
The objective of this study was to prospectively evaluate changes in echocardiographic 264 
measures, morphologic variables and blood markers in healthy cats from 6 months to 24 months 265 
of age. Results showed significant changes over time for both dependent and independent variables, 266 
as well as associations between dependent variables and independent variables, the latter both 267 
expressed as absolute measure as well as change over 6 months’ time. This was to investigate 268 
whether echocardiographic measures are associated to morphologic variables and blood markers 269 
at a specific time point, but also to investigate whether echocardiographic measures are associated 270 
to changes in these morphologic variables and blood markers, i.e. measured IGF-1 concentration 271 
but also an increase in IGF-1 would be associated with an echocardiographic measure. 272 
The 2D-IVSd was associated with HL, and  also to changes in HL in the previous 6 months. 273 
Comparable findings of echocardiographic measurements associated with measures of head size 274 
have been described in cats with cardiac pathologies. One previous study that excluded Maine coon 275 
cats4 identified an association between hypertrophic cardiomyopathy (HCM) and HW and HL, and 276 
a study in 28 cats of varying breeds (including 4 Maine coon cats) only showed an association 277 
between LVH and HW.2  The results of this study contributes to the hypothesis of a relationship 278 
between cardiac and body size, not only in cats with cardiac pathologies but also in healthy cats. 279 
Because cats in the current study were only followed until 24 months of age and none of the cats 280 
had developed cardiac pathologies at that age, it is unclear whether this association in these young 281 
cats has a predictive value for development of cardiac pathology later in life.  282 
2-D-IVSd was also significantly associated with the change in IGF-1 in the 6 months before 283 
that time point. Two previous studies in cats showed a significant association between IGF-1 and 284 
LVH2 or HCM,5 and the results described here contribute to the general understanding of the 285 
relationship between cardiac measures and body size and the mechanism behind this relationship. 286 
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The change in IGF-1 concentration between separate time points, but not the IGF-1 concentration 287 
at time points itself, was associated with LA:Ao, 2-D-IVSd and 2-D-LVWd. It can be hypothesized 288 
that an increasing IGF-1 concentration and/or variation in IGF-1 concentration have an influence 289 
on cardiac measures. To the authors’ knowledge, no studies have reported IGF-1 concentrations 290 
during growth in cats.  However, in humans, serum IGF-1 concentrations increase during growth, 291 
with peak values at puberty.27  In the current study, the highest mean IGF-1 concentration occurred 292 
at 12 months of age.  None of the cats showed signs of hypersomatotropism28, therefor acromegaly 293 
was not suspected in these cats.  294 
The other variable associated with measures of left ventricular thickness was NT-proBNP.  295 
The M-LVWd was associated with NT-proBNP, and 2-D-LVWd was also associated to changes 296 
in NT-proBNP in the 6 months before to that time point. It is important to note, however, that there 297 
were only 2 cats that had NT-proBNP concentrations >100 pmol/L at any time point, and they were 298 
without cardiac abnormalities or an identified cause for elevated NT-proBNP. Previously, NT-299 
proBNP showed associations with measures of cardiac size in cats  with LVH2 or HCM,29, 30 though 300 
the results in the current study suggest there might be a comparable association in healthy cats as 301 
well. NT-proBNP is secreted from cardiac myocytes during cardiac myocyte stretch, pressure 302 
overload, and neurohormonal stimuli,29 which are all processes that may intermittently occur 303 
during cardiac growth. While other studies of NT-proBNP have included at least some cats <2 yrs 304 
of age,30-32 none have reported NT-proBNP concentrations for healthy cats during the first 2 years 305 
of life.  306 
There was no significant association between BCS and any echocardiographic 307 
measurement, though it should be noted that 88% of cats in the current study were overweight by 308 
the time they were 18 months of age, likely due to the cats being fed ad libitum since birth.  309 
Therefore, the weight of a cat at 18 or 24 months of age does not necessarily reflect the cat’s body 310 
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size and cardiac measures. However, BW was associated with 2-D-LVWd, Ao and LA, and 311 
changes in BW were associated with Ao. Previous studies have shown comparable associations 312 
between BW and left ventricular measures in healthy cats,11, 13, 16-18 though the study described here 313 
is the first to examine cats at different time points in life and including BCS. The associations 314 
between BW and 2-D-LVWd, Ao and LA suggest that healthy larger cats simply have larger hearts, 315 
however if the reason for the association between BW and left ventricular measurements was 316 
merely the result of larger cats having larger, thicker hearts, one would expect that BW in adulthood 317 
would be associated with all echocardiographic measures and not only measures of the left 318 
ventricle.  Also, variables that were associated with measures of left ventricular thickness in the 319 
current study (i.e., BW, head size, NT-proBNP, and IGF-1) have been associated with LVH or 320 
HCM in previous studies.2, 4, 5 The association between obesity and left ventricular hypertrophy has 321 
been described in humans,33 dogs,34 and cats,5 though it is still unclear whether this also exists for 322 
cats with healthy cardiac function.  323 
One notable finding from the current study was wide variation in cats’ BW, growth rates, 324 
and BCS (Table 1) even though the cats had identical housing, handling, and were all fed the same 325 
diet ad libitum.  This may be due to genetic factors since cats were from 11 different litters or to 326 
individual variability, although the sample size was too small to evaluate these factors in more 327 
detail.  In addition, while male cats are predisposed to HCM, all cats in the current study were 328 
female so their risk may have been lower than in the general population.  Studying the role of early 329 
growth and nutrition on the heart in a controlled situation is advantageous although results would 330 
need to be confirmed in a home environment and in cats of different breeds and gender. 331 
There are important limitations to the current study.  Most importantly, cats were only 332 
studied until 2 years of age so it is not known if any of these cats will develop HCM or LVH later 333 
in life.  Longer longitudinal studies are needed to determine the relationship between early growth 334 
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and the development of HCM or other cardiac pathologies over the course of cats' lifetimes.  It can 335 
be hypothesized whether the results observed can be due to variability in obtaining ultrasound 336 
images and performing measurements on them. Intra-observer variability of echocardiographic 337 
measurements was investigated by Chetboul et al. 35, showing that increased experience of the 338 
observer decreases the coefficient of variation of within- and between-day repeated measurements. 339 
The board-certified veterinary cardiologist [DJC]) has a longtime experience in performing 340 
echocardiography in cats, thereby limiting possible influence of variability on the results. The 341 
results of this study also may not be generalizable to pet cats, given that these were of a single 342 
breed from 11 litters and were housed in a colony situation, with a controlled environment.  343 
However, the feeding situation is not unlike that in many households where cats are fed ad libitum.  344 
In one study of Maine Coon cats, the percentage of cats fed ad libitum was 89% during growth and 345 
90% as adults.5  Evaluations did not begin until 6 months of age so very early differences in growth 346 
may have been missed and should be considered for evaluation in future studies. Nonetheless, 347 
although cats are clinically considered to reach maturity by 1 year of age, physeal closure of some 348 
long bones in the cat does not occur until as late as 25 months of age, so some growth is possible 349 
after 1 year. In fact, bones of the skull may fuse even later with sphenoid, frontal, parietal, and 350 
temporal bone not fusing until 2-4 years of age,36 which could explain the increased head size 351 
between 12 and 18 months of age. In the current study, body weight continued to increase until the 352 
24 months’ time point which could be partially due to continued growth. Body condition score 353 
increased only until 12 months of age, therefore the increase in bodyweight due to development of 354 
obesity is less likely. Despite the evaluations starting only at the age of 6 months, this study is still 355 
the first to describe echocardiographic measurements in cats repeatedly examined at different time 356 
points in early-adult life. Only one measure of skeletal size (i.e., head size, as assessed by HL and 357 
HW) was used.4  Other studies have looked at humerus length or vertebral size which may provide 358 
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useful information since it is likely to be less influenced by breed than head size.4, 5 In addition, 359 
cats in the current study were fed a single diet which was changed at 3 time points during the study.  360 
Diet has been described to alter echocardiographic measurements in cats with HCM37 and rodent 361 
models of cardiomyopathy38, 39, therefore this also could have influenced the results of the study.  362 
Different diets or even keeping the cats on the same diet for the duration of the study may have 363 
yielded different results.  A variety of other factors could have influenced the results, including 364 
genetic and epigenetic influences, as well as behavioral factors that could influence food intake 365 
and, therefore, growth.  A final limitation is the relatively small sample size which limited the 366 
number of multivariable comparisons that could be made.  Larger studies could help to identify 367 
other potential associations with the outcome variables.   368 
 369 
Conclusions 370 
Associations between body and cardiac size have been described in adult cats and cats with cardiac 371 
hypertrophy. This study suggests comparable associations in healthy cats evaluated in early adult 372 
life, however future studies including a larger number of cats and more time points earlier in life 373 
are needed to determine any potential relationship between early growth in cats and 374 
echocardiographic measurements as indicators of development of heart disease or cardiac 375 
hypertrophy later in life. 376 
  377 
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Tables 
Table 1. Morphologic variables and blood markers at 6, 12, 18 and 24 months of age in 24 healthy 
cats. Data are presented as median (range). Different superscript letters identify within-group 
comparison (P <0.05).  
 6 months 12 months 18 months 24 months 
Effect of 
time 
BW (kg) 
2.7 
(2.1-3.4)a 
3.6 
(2.6-4.5)b 
4.5 
(3.3-5.8)c 
4.3 
(3.0-5.4)d 
<0.0001 
BCS (1-9) 
5 
(5-6)a 
6 
(5-8)b 
7 
(5-8)b 
6 
(5-8)b 
<0.0001 
HL (cm) 
90.65 
(84.20-
96.80)a 
99.81 
(93.38-
106.70)b 
101.99 
(92.91-
108.57)c 
101.08 
(91.31-
109.96)bc 
<0.0001 
HW (cm) 
58.30 
(55.8-62.1)a 
67.20 
(64.37-
70.86)b 
68.07 
(62.67-
72.01)b 
68.26 
(63.21-71.89)b 
<0.0001 
IGF-1 
(ng/mL) 
260.7 
(103.6-
424.1)a 
452.7 
(152.1-
923.7)b 
372.1 
(166.3-
630.8)c 
343 
(116-531)ac 
<0.0001 
NT-proBNP 
(pmol/L) 
44 
(24-117)a 
33 
(24-78)b 
25 
(24-77)b 
24 
(24-122)b 
<0.0001 
18 
 
 
BW, body weight; BCS, body condition score; HL, head length; HW, head width; IGF-1, insulin-
like growth factor-1; NT-proBNP, N-terminal B-type natriuretic peptide 
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Table 2 - Echocardiographic measurements (in mm) at 6, 12, 18, and 24 months of age in 24 
healthy cats. Data are presented as median (range). Different subscript letters identify within-group 
comparison (P <0.05).   
 6 months 12 months 18 months 24 months 
Effect of 
time 
2-D-LVIDd 
13.5 
(11.5-17.1)a 
14.6 
(12.8-
17.3)b 
10.0 
(12.1-
17.0)ab 
14.4 
(12.1-16.4)ab 
0.001 
2-D-IVSd 
4.0 
(3.2-5.0)a 
4.3  
(3.1-5.2)b 
4.8 
(3.4-5.9)c 
4.5 
(3.5-5.4)bc 
<0.0001 
2-D-LVWd 
3.8 
(3.0-4.4)a 
4.3 
(3.4-4.9)b 
4.3 
(3.3-4.9)b 
4.2 
(3.4-4.7)b 
<0.0001 
Aorta (short axis) 
7.9 
(7.2-9.2)a 
8.5 
(7.6-9.6)b 
8.7 
(7.6-
10.1)bc 
8.9 
(7.8-10.2)c 
<0.0001 
Left atrium (short 
axis) 
10.8 
(8.8-12.4)a 
11.4 
(10.3-
13.6)b 
11.8 
(10.1-
13.5)b 
11.8 
(10.1-13.5)b 
0.0002 
Lefta atrium : 
Aorta 
1.3 
(1.1-1.6)a 
1.4 
(1.2-1.5)a 
1.3 
(1.1-1.5)a 
1.3 
(1.1-1.5)a 
0.7564 
M-LVIDd 
13.4 
(9.2-14.7)a 
14.5 
(12.8-
18.1)b 
13.6 
(11.3-
16.9)ab 
14.5 
(11.8-17.0)b 
0.0001 
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M-IVSd 
4.0 
(2.7-4.8)a 
4.7 
(3.2-5.5)b 
4.9 
(3.8-5.9)b 
4.8 
(3.7-5.8)b 
<0.0001 
M-LVWd 
4.0 
(2.8-5.1)a 
4.4 
(3.1-5.1)b 
4.4 
(3.3-5.4)b 
4.4 
(3.1-5.7)b 
0.0003 
2-D-LVIDd, 2-D-mode end-diastolic left ventricular internal diameter in diastole; 2-D-IVSd, 2-D-
mode end-diastolic interventricular septum in diastole; 2-D-LVWd, 2-D-mode end-diastolic left 
ventricular free wall in diastole; M-LVIDd, M-mode end-diastolic left ventricular internal 
diameter in diastole; M-IVSd, M-mode end-diastolic interventricular septum in diastole; M-
LVWd, M- mode end-diastolic left ventricular free wall in diastole.  
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Table 3 -  Associations between dependent variables (2-D-LVIDd, 2-D-IVSd, 2-D-LVWd, Ao, 
LA, LA:Ao, M-IVSd, M-LVIDd and M-LVWd) and the independent morphologic variables (BW, 
BCS, HL and HW), blood markers (IGF-1 and log transformed NT-proBNP) and time in 24 
healthy cats.  
R2 : Coefficient of determination of the model. Independent variables selected by stepwise 
regression are presented. For abbreviations, see Table 2 legend. 
 
Body 
weigh
t 
Body 
conditi
on 
score 
Head 
length 
Head 
widt
h 
NT-
proBNP 
(log 
transform
ed) 
IGF-1 Time R2 
LVIDd - - - 
0.02
11 
- - 0.0285 0.44 
IVSd - - 
0.029
3 
- - - 0.0012 0.58 
LVWd 
0.005
7 
- - 
0.01
90 
- - 0.0016 0.47 
Ao (short 
axis) 
<0.00
01 
- - - - - - 0.58 
LA (short 
axis) 
<0.00
01 
- - - - - - 0.27 
LA:Ao - - - - - - 0.0328 NA  
M-LVIDd - - - - - - 0.0001 NA 
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M-IVSd - - - - - - 0.0001 NA 
M-LVWd - - 
<0.00
01 
- 0.0318 - - 0.47 
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Table 4 Significant associations between dependent variables (2-D-LVIDd, 2-D-IVSd, 2-D-
LVWd, Ao, LA, LA:Ao, M-IVSd, M-LVIDd and M-LVWd) at 12, 18 and 24 months and 
evolution of independent morphologic variables (BW, BCS, HL and HW), blood markers (IGF-1 
and log transformed NT-proBNP) in 24 healthy cats in the previous 6 months  
R2 : Coefficient of determination for the significant associations other than Time alone. 
Independent variables selected by stepwise regression are presented.  For abbreviations, see Table 
2 legend. 
 Bodyweight 
Body 
condition 
score 
Head 
length 
Head 
width 
NT-proBNP 
(log 
transformed) 
IGF-1 Time R2 
2-D-
LVIDd 
- - - - - - 0.0240 NA  
2-D-
IVSd 
- - 0.0037 - - 0.0062 0.0005 0.60 
2-D-
LVWd 
- - 0.0246 - 0.0206 0.0119 - 0.34 
Ao (short 
axis) 
0.0390 - - - - - 0.0029 0.47 
LA (short 
axis) 
- - - - - - - - 
LA:Ao - - - - - 0.0297 - 0.30 
M-
LVIDd 
- - - - - - - - 
24 
 
 
M-IVSd - - - - - - 0.0411 NA 
M-
LVWd 
- - - - - - - - 
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